GlassScriptPhysician profile
Brian Arwood
NPI 1073280426
$637.92
in general payments reported to CMS, 2019-2025
16 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $306 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $132.25 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $69.68 | 2024 | Spravato |
| Teva Pharmaceuticals USA, INC. | $49.48 | 2024-2025 | Austedo Xr, Austedo Xr |
| Axsome Therapeutics, INC. | $43.20 | 2025 | Auvelity |
| Neos Therapeutics, LP | $42.46 | 2024-2025 | Adzenys Xr-Odt |
| Noven Therapeutics, LLC | $38.34 | 2024 | Xelstrym |
| Ironshore Pharmaceuticals INC. | $34.37 | 2024 | |
| Alkermes, INC. | $33.15 | 2024-2025 | Aristada, Lybalvi |
| Abbvie INC. | $32.28 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.85 | 2024 | Trintellix |
| Tris Pharma INC | $29.10 | 2024 | Dyanavel Xr |
| Biogen, INC. | $27.03 | 2025 | Zurzuvae |
| Lilly USA, LLC | $21.85 | 2025 | Zepbound |
| Neurocrine Biosciences, INC. | $18.74 | 2025 | |
| Corium, LLC | $17.50 | 2025 | Azstarys |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $16.64 | 2025 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Arwood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.